Quick Answer
SELLAS Life Sciences Group, Inc. reported Net Income Loss of -$26.86 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +13.0% in Net Income Loss from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$9.29 million | Q2 2013: $5.39 million | Q3 2013: -$6.93 million | Q4 2013: -$5.52 million | Q1 2014: -$2.54 million | Q2 2014: -$19.94 million | Q3 2014: -$6.17 million | Q1 2015: -$10.54 million | Q2 2015: -$15.66 million | Q3 2015: -$18.03 million | Q1 2016: -$16.49 million | Q2 2016: $5.39 million | Q3 2016: -$6.93 million | Q1 2017: -$4.60 million | Q2 2017: -$5.91 million | Q3 2017: -$4.46 million | Q1 2018: -$8.00 million | Q2 2018: -$6.06 million | Q3 2018: -$290.0 thousand | Q1 2019: -$4.54 million | Q2 2019: -$3.13 million | Q3 2019: -$4.20 million | Q1 2020: -$4.14 million | Q2 2020: -$4.43 million | Q3 2020: -$4.47 million | Q1 2021: -$2.40 million | Q2 2021: -$4.61 million | Q3 2021: -$7.09 million | Q1 2022: -$16.74 million | Q2 2022: -$8.41 million | Q3 2022: -$7.02 million | Q1 2023: -$11.10 million | Q2 2023: -$8.84 million | Q3 2023: -$9.27 million | Q1 2024: -$9.57 million | Q2 2024: -$7.47 million | Q3 2024: -$7.11 million | Q1 2025: -$5.81 million | Q2 2025: -$6.60 million | Q3 2025: -$6.79 million.
- Over the full 16 years of available data (2010 to 2025), SELLAS Life Sciences Group, Inc.'s Net Income Loss has declined by 124.0%.
- Historical annual values: Fiscal year 2025: -$26.86 million | Fiscal year 2024: -$30.88 million | Fiscal year 2023: -$37.34 million | Fiscal year 2022: -$41.30 million | Fiscal year 2021: -$20.70 million | Fiscal year 2020: -$16.76 million | Fiscal year 2019: -$19.29 million | Fiscal year 2018: -$27.67 million | Fiscal year 2017: -$23.75 million | Fiscal year 2016: -$17.68 million | Fiscal year 2015: -$63.90 million | Fiscal year 2014: -$36.61 million | Fiscal year 2013: -$76.68 million | Fiscal year 2012: -$34.97 million | Fiscal year 2011: -$11.49 million | Fiscal year 2010: -$11.99 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: